Literature DB >> 20557933

Safety and efficacy of bortezomib, melphalan and low doses dexamethasone (VM-dex) in newly diagnosed patients with multiple myeloma.

Alessandro Gozzetti, Marzia Defina, Monica Bocchia, Alberto Fabbri, Elena Marchini, Ida Chitarrelli, Francesco Lauria.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20557933     DOI： 10.1016/j.leukres.2010.05.025

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  1 in total

1.  Light chain multiple myeloma, clinic features, responses to therapy and survival in a long-term study.

Authors:  Jia-jia Zhang; Wan-jun Sun; Zhong-xia Huang; Shi-lun Chen; Yu-ping Zhong; Ying Hu; Na An; Men Shen; Xin Li
Journal:  World J Surg Oncol       Date:  2014-07-28       Impact factor: 2.754
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.